This may indicate a link between MS severity and reduced CYP17A1 functioning in the hydroxylase step, which is primarily active in the adrenal zona fasciculata but negligible in the CNS for both its hydroxylase and lyase functions. This evidence concerns the gene CYP17A1 and myeloid sarcoma.